These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12746753)

  • 1. Androgen-induced vasorelaxation: a potential vascular protective effect.
    Perusquía M
    Exp Clin Endocrinol Diabetes; 2003 Apr; 111(2):55-9. PubMed ID: 12746753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Influence of androgens on cardiovascular system in men].
    Barud W; Palusiński R; Hanzlik J
    Wiad Lek; 2001; 54(5-6):325-32. PubMed ID: 11556215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasodilating mechanisms of testosterone.
    Yildiz O; Seyrek M
    Exp Clin Endocrinol Diabetes; 2007 Jan; 115(1):1-6. PubMed ID: 17286226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of androgens on the cardiovascular system.
    Rosano GM; Cornoldi A; Fini M
    J Endocrinol Invest; 2005; 28(3 Suppl):32-8. PubMed ID: 16042358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgens and morphologic remodeling at penile and cardiovascular levels: a common piece in complicated puzzles?
    Mirone V; Imbimbo C; Fusco F; Verze P; Creta M; Tajana G
    Eur Urol; 2009 Aug; 56(2):309-16. PubMed ID: 19147269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correction of cardiovascular pathology in men with age-dependent androgen deficiency (review)].
    Ametov AS; Vertkin AL; Morgunov LIu; Arinina EN; Naumov AV
    Ter Arkh; 2007; 79(10):50-3. PubMed ID: 18154146
    [No Abstract]   [Full Text] [Related]  

  • 7. New perspectives on Mars and Venus: unravelling the role of androgens in gender differences in cardiovascular biology and disease.
    Ng MK
    Heart Lung Circ; 2007 Jun; 16(3):185-92. PubMed ID: 17448726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of prostate cancer by androgens: experimental paradox or clinical reality.
    Algarté-Génin M; Cussenot O; Costa P
    Eur Urol; 2004 Sep; 46(3):285-94; discussion 294-5. PubMed ID: 15306098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cardiovascular comorbidity in rheumatic disease. Does sex play a role?].
    Kung M; Störk S; Angermann CE
    Herz; 2005 Sep; 30(6):512-21. PubMed ID: 16170682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgens, cardiovascular disease and osteoporosis.
    Isidori AM; Giannetta E; Pozza C; Bonifacio V; Isidori A
    J Endocrinol Invest; 2005; 28(10 Suppl):73-9. PubMed ID: 16550728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testosterone and blood pressure regulation.
    Kienitz T; Quinkler M
    Kidney Blood Press Res; 2008; 31(2):71-9. PubMed ID: 18319594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testosterone as a modulator of vascular behavior.
    Littleton-Kearney M; Hurn PD
    Biol Res Nurs; 2004 Apr; 5(4):276-85. PubMed ID: 15068657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correction of androgen deficiency in elderly patients].
    Morgunov LIu
    Klin Med (Mosk); 2007; 85(9):17-22. PubMed ID: 18038561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy and safety of hormonal therapy with androgens (androgel) in men with erectile dysfunction, partial androgen deficiency of aging male and cardiovascular diseases].
    Kalinchenko SIu; Vorslov LO; Aglamazian NL; Morgunov LIu
    Urologiia; 2007; (1):57, 59-61. PubMed ID: 17472002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular effects of ambient particulate matter instillation in spontaneous hypertensive rats.
    Bagate K; Meiring JJ; Gerlofs-Nijland ME; Vincent R; Cassee FR; Borm PJ
    Toxicol Appl Pharmacol; 2004 May; 197(1):29-39. PubMed ID: 15126072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dark side of testosterone deficiency: III. Cardiovascular disease.
    Traish AM; Saad F; Feeley RJ; Guay A
    J Androl; 2009; 30(5):477-94. PubMed ID: 19342698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen excess and cardiovascular risk.
    Rizzo M; Rini GB; Carmina E
    Minerva Endocrinol; 2007 Mar; 32(1):67-71. PubMed ID: 17353867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sildenafil: emerging cardiovascular indications.
    Raja SG; Nayak SH
    Ann Thorac Surg; 2004 Oct; 78(4):1496-506. PubMed ID: 15464535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dipyridamole, cerebrovascular disease, and the vasculature.
    Chakrabarti S; Freedman JE
    Vascul Pharmacol; 2008; 48(4-6):143-9. PubMed ID: 18342579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testosterone and vascular reactivity.
    Iliescu R; Reckelhoff JF
    Clin Sci (Lond); 2006 Oct; 111(4):251-2. PubMed ID: 16681461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.